41
Presenter A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal Scientist BioPharma Solutions September, 2012

Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Embed Size (px)

Citation preview

Page 1: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Presenter

A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals

Steven L. Nail, Ph.D. Principal Scientist BioPharma Solutions September, 2012

Page 2: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Elements of QbD 2

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

Assurance of product quality through design of robust formulations and processes

Scientific understanding of how formulation and processing affect product performance

Ability to effect continuous improvement

Reduced regulatory burden over life of product

Page 3: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

However… 3

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

One of the biggest obstacles to implementation of the QbD regulatory paradigm appears to be lack of understanding by the pharmaceutical industry

This is particularly true for parenteral products when compared to solid oral dosage forms

Page 4: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Key Features of a Quality by Design Approach 4

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

Application of prior knowledge in establishing an experimental approach

Some type of formalized risk assessment process

Definition of formulation and process design spaces

Page 5: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

“Traditional” Approach to Freeze-Dry Cycle Development 5

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

Largely by trial and error, identify freeze-dry process conditions that produce an acceptable product

Establish “proven acceptable ranges” around process variables such as shelf temperature, chamber pressure, and shelf temperature ramp rates during transitions from one phase of the process to another

Page 6: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

The Big Picture

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

6

Knowledge Space

Design Space

Control Space

Page 7: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

QbD Approach to Cycle Development 7

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

Identify optimal processing conditions based on a thorough understanding of the process, and know where the edges of failure are

Page 8: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Design Space Layout for Primary Drying

Chamber P

Subl

imat

ion

Rat

e

-10 C

0 C

+10 C

+20 C

+30 C Product T -20 C

-25 C

-30 C -35 C

-40 C

Page 9: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Cake Appearance

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

9

Failure

Page 10: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Cycle Design with Equipment Capability

Chamber P

Subl

imat

ion

Rat

e

-10 C

0 C

+10 C

+20 C

+30 C

-25 C

Freeze Dryer Capability Product T

Cooling or Heating Power

Gas Flow

Page 11: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

11

Chamber P

Subl

imat

ion

Rat

e The Optimum Cycle Follows from the Design Space Concept

Acceptable Zone

Optimum

Page 12: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Outline of Steps 12

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

Characterize the formulation and identify the failure mode

– Eutectic melting (“melt-back”) – Collapse – Powder ejection from the vial? – Others?

Page 13: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Differential Scanning Calorimeter (DSC)

Page 14: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Thermal Transitions in Frozen Systems

Page 15: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Freeze Drying Microscope

Page 16: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Microscope View of Frozen Formulation

Page 17: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Crystallization of Drug During Annealing

Page 18: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Freeze Drying with Retention

Page 19: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Onset of Collapse

Page 20: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Further Collapse

Page 21: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Outline of Steps 21

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

Based on the above data, run trial lots intended to make the product fail during primary drying

– Confirm the failure mode

Page 22: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Outline of Steps 22

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

Establish the relationship between the process variables you control (shelf temperature and chamber pressure) and the one you don’t directly control (product temperature)

– Measure the vial heat transfer coefficient, Kv, as a

function of chamber pressure – Measure the resistance of the dried product layer, Rp, to

flow of water vapor

Page 23: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Coupled Heat and Mass Transfer

Page 24: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Equations for Heat and Mass Transfer

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

24

dq/dt = KvAv (Ts –Tb) dm/dt = Ap (Pi – Pc)/Rp dq/dt = ∆Hs dm/dt

Page 25: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Where, 25

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

dq/dt = rate of heat transfer Kv = vial heat transfer coefficient Av = cross sectional area of vial (outside) Ts = shelf temperature Tb = temperature of product at bottom of vial dm/dt = mass flow rate of water vapor Ap = cross sectional area of product (inside of vial) Pi = vapor pressure of ice at sublimation front Pc = pressure in the chamber (in Torr) Rp = resistance of dried product layer ∆Hs = heat of sublimation of ice

Page 26: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

How to measure sublimation rate? 26

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

Tunable Diode Laser Absorption Spectroscopy

– TDLAS is a near-IR based instrument that measures the

instantaneous mass flow rate of water vapor from the chamber to the condenser by “looking” through the connecting duct, or spoolpiece, connecting the two

Page 27: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

TDLAS Instrumentation

Page 28: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

What if you don’t have access to TDLAS? 28

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

Smart Freeze Dryer software should work

It can be done gravimetrically (but it’s tedious)

Page 29: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Measurement of Kv

Fill the intended vial with the intended volume of water. Note: We use one full tray in the LyoStar Place thermocouples in the bottom center of several vials – minimum of three Carry out the freeze dry cycle at an appropriate shelf temperature and at the low end of the intended pressure range Monitor mass flow rate by TDLAS until it stabilizes, then change to a new pressure set point. Keep repeating until you’ve covered the selected pressure range Calculate Kv at each pressure using the relationship:

Kv = DHs dm/dt/[Av(Ts – Tb)]

Page 30: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Example: Pressure (mT) Kv (joules/hr-cm2- oK) 25 3.58 50 5.25 75 6.11 100 7.24 125 8.20 150 9.01 175 9.75 200 10.31 250 11.21 300 12.07 350 12.92 400 13.77

Page 31: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Measurement of Rp

Fill the intended vial with the correct volume of formulation in the intended vial and run a trial cycle Place thermocouples in at least three vials Monitor mass flow rate by TDLAS Calculate Rp as follows:

Rp = Ap(Pi – Pc)/(dm/dt) where

Pi (in Torr) = 2.698 x 1010exp (-6144.96/Tb)

Page 32: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Mass Flow Rate vs. Time

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

32

Note: We use a value of Rp near the end of 1° drying. In this example, we use a value of 5.94 Torr-hr-cm2-gm-1

020406080

100120140160

0.00 1.00 2.00 3.00 4.00 5.00 6.00

Time (hrs)

Mas

s Fl

ow R

ate

(g/h

r)

-50-40-30-20-10010203040

Prod

uct T

empe

ratu

re (C

)

Primary Drying for Sodium Ethacrynate

Page 33: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Calculate the Design Space

1. Choose an arbitrary value for Ts and Pc

2. Calculate the corresponding values of Tb and dm/dt

DHs Ap (Pi –Pc) = Kv Av(Ts – Tb) Rp

or,

{DHs Ap[2.698 x 1010exp (-6144.96/Tb) – Pc]}/Rp

= KvAv(Ts – Tb)

Solve this iteratively for Tb

Construct Shelf Temperature and Product Temperature Isotherms

Page 34: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Design Space Calculations (continued)

3. Now calculate the corresponding mass flow rate by

dm/dt = KvAv (Ts – Tb)

4. Now choose a new value of Pc at the same Ts

5. Repeat this process for several values of Pc. The resulting plot of mass flow rate vs. pressure generates one shelf temperature isotherm

Page 35: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Design Space Calculations (continued)

6. Choose a new value of Ts and repeat the previous steps. This then generates a set of shelf temperature isotherms. They are non-linear, so several pressure data points are needed for each shelf temperature isotherm

Page 36: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

0

0.05

0.1

0.15

0.2

0.25

0.3

0.35

0.4

0 0.1 0.2 0.3 0.4 0.5

Pressure (Torr)

Mas

s Fl

ux (g

/cm

^2hr

)

Ts=0oC Ts=10oC Ts=20oC Ts=30oC Ts=40oC

Shelf Temperature Isotherms

Page 37: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Design Space Calculations (continued)

7. Generate the product temperature isotherms by choosing an arbitrary product temperature, Tb,

and a chamber pressure, Pc 8. Calculate the sublimation rate under these

conditions by

dm/dt = Ap[2.698 x 1010exp (-6144.96/Tb) – Pc] Rp

Note: The product temperature isotherms are linear, so only two pressures are needed for each value of Tb

Page 38: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

00.050.1

0.150.2

0.250.3

0.350.4

0.45

0 0.1 0.2 0.3 0.4 0.5

Pressure (Torr)

Mas

s Fl

ux (g

m/c

m^2

hr)

0oC 10oC

20oC 30oC 40oC

-10oC

-15oC

-20oC

-25oC

Primary Drying Design Space

Page 39: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Next Step. . . . 39

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

Add the equipment capability curve – the maximum sublimation rate supported by the equipment as a function of pressure

We do this by ice slab testing

Page 40: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Equipment Capability Curve

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

40

= Choke Point

Page 41: Quality by Design Approach to Cycle Development and ... A Quality by Design Approach to Cycle Development and Optimization for Freeze-Dried Parenterals Steven L. Nail, Ph.D. Principal

Advantages of This Approach 41

Baxter Confidential © 2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.

It results in a truly optimum cycle – not just a “pretty good” one

It maximizes process/product

understanding with a minimum of experimentation

It facilitates handling of process deviations It’s strongly connected to the QbD philosophy